A Randomized Controlled Trial Investigating the Effects of a Special Extract of Bacopa monnieri (CDRI 08) on Hyperactivity and Inattention in Male Children and Adolescents: BACHI Study Protocol (ANZCTRN12612000827831)
James D Kean, Jordy Kaufman, Justine Lomas, Antionette Goh, David White, David Simpson, Andrew Scholey, Hemant Singh, Jerome Sarris, Andrea Zangara, Con Stough
NUTRIENTS | MDPI | Published : 2015
UNLABELLED: Clinical diagnoses of Attention Deficit Hyperactivity Disorder (ADHD) and the use of prescription medications for its treatment have increased in recent years. Current treatments may involve the administration of amphetamine-type substances, a treatment path many parents are apprehensive to take. Therefore, alternative pharmacological treatments are required. Few nutritional or pharmacological alternatives that reduce ADHD associated symptoms (hyperactivity and inattention) have been subjected to rigorous clinical trials. Bacopa monnieri is a perennial creeping herb. CDRI 08 is a special extract of Bacopa monnieri which has been subjected to hundreds of scientific studies and has..View full abstract
This study was funded by a grant from Soho Flordis International Research (SFIR). CS is supported by grants from the Australian Research Council (ARC) and the National Health and Medical Research Council (NHMRC). CDRI 08 is marketed in several countries as KeenMind (R).